The total gluteus maximus rotation and other gluteus maximus musculocutaneous flaps in the treatment of pressure ulcers

1986 ◽  
Vol 39 (1) ◽  
pp. 66-71 ◽  
Author(s):  
Satya Parkash ◽  
S. Banerjee
Medicine ◽  
2017 ◽  
Vol 96 (47) ◽  
pp. e8829 ◽  
Author(s):  
Xing Liu ◽  
Wan Lu ◽  
Yidong Zhang ◽  
Yun Liu ◽  
Xinghua Yang ◽  
...  

2011 ◽  
Vol 8 (3-4) ◽  
pp. 345-359 ◽  
Author(s):  
Hilton M. Kaplan ◽  
Lucinda L. Baker ◽  
Salah Rubayi ◽  
Gerald E. Loeb

Objective:BIONs™ (BIOnic Neurons) are injectable, wireless microstimulators that make chronic BION Active Seating (BAS) possible for pressure ulcer prevention (PUP). Neuromuscular electrical stimulation (NMES) produces skeletal motion and activates trophic factors, counteracting three major etiological mechanisms leading to pressure ulcers (PUs): immobility, soft-tissue atrophy, and ischemia. Companion papers I and II reviewed prior experience with NMES for PUP, and analyzed the biomechanical considerations, respectively. This paper presents a treatment strategy derived from this analysis, and the clinical results of the first three cases.Methods:Two BIONs implanted (one on inferior gluteal nerve to gluteus maximus (GM), and other on sciatic nerve to hamstrings (HS)), in 3 spinal cord injured (SCI) subjects already undergoing gluteal rotation flaps for PUs. BAS using HS when seated, and BION Conditioning (BC) via GM+HS when non-weightbearing. Follow-up: 1 yr, including 6 mo. treatment window (interface pressure mapping; muscle perfusion scans; MRI, X-ray volume assessments).Results:Successfully implanted and activated both desired muscle groups, selectively, in all. No PU recurrences or wound complications. Two subjects completed protocol. Mean results: Interface: contact pressure −10%; maximum pressure −20%; peak pressure area −15%. Vascularity: GM +20%, HS +110%. Perfusion: GM +70%, HS +440%. Muscle volume: GM +14%, HS +31%. Buttock soft-tissue padding: +49%. 1 BION failed; 1 BION rotated under GM.Conclusions:Promising proof-of-concept data supporting the feasibility of implanted microstimulators to achieve sufficiently strong and selective activation of target muscles for PUP. Ultimate goal is prophylactic deployment through bilateral, nonsurgical injection of BIONs in chronically immobile patients.


2002 ◽  
Vol 15 (3) ◽  
pp. 149 ◽  
Author(s):  
Wu Chul Song ◽  
Sung Man Bae ◽  
Beob Yi Lee ◽  
Seung Ho Han ◽  
Ki Seok Koh

2011 ◽  
Vol 8 (3-4) ◽  
pp. 333-343
Author(s):  
Hilton M. Kaplan ◽  
Lucinda L. Baker ◽  
Rahman Davoodi ◽  
Nga Ting Wong ◽  
Gerald E. Loeb

Background:Pressure ulcers (PUs) are common and debilitating wounds that arise when immobilized patients cannot shift their weight. Neuromuscular Electrical Stimulation (NMES) has been investigated for Pressure Ulcer Prevention (PUP) for over 20 years. Historically gluteus maximus (GM) has been considered an important actuator in attempting to redistribute seated pressures through NMES.Methods:Analysis of skeletal biomechanics to quantify the value of GM relative to hamstring hip extensors (HS), using muscle moment models based on torques and rigid body mass estimates from the literature. Surface stimulation experiments (n= 10 + 1,non-paralyzed) to validate model and identify promising stimulation sites and treatment strategies that would approximate healthy biomechanics.Results:Literature values and Rigid Body Analysis estimate: ~63 Nm extensor torque requirement calculated for complete ipsilateral unloading of the buttocks. Muscle Moment Analysis: GM can provide 70% of total hip extensor torque when walking vs. 18% when seated. HS can provide 100 Nm hip extension torque when seated, exceeding 63 Nm requirement. Surface Stimulation: ipsilateral seated interface pressure mean −26% during HS stimulation vs. +16% with GM; peak pressure area −94% HS vs. +213% GM.Conclusions:GM activation reduces disuse atrophy and improves circulation, but appears neither required, nor desired, for unloading when seated. HS stimulation alone should be capable of sufficient unloading. This new proposed approach is explored clinically in companion paper III.


Sign in / Sign up

Export Citation Format

Share Document